Hong Zhao
Qingdao University(CN)Sun Yat-sen University(CN)Chinese Academy of Medical Sciences & Peking Union Medical College(CN)Nankai University(CN)Peking Union Medical College Hospital(CN)Xian Central Hospital(CN)Shanghai University of Traditional Chinese Medicine(CN)Fifth Affiliated Hospital of Sun Yat-sen University(CN)People's Hospital of Cangzhou(CN)Affiliated Hospital of Qingdao University(CN)Shenzhen Luohu People's Hospital(CN)Tianjin Medical University Eye Hospital(CN)CM Hospital(KR)Shandong First Medical University(CN)China Agricultural University(CN)Tianjin Medical University(CN)
Publications by Year
Research Areas
Hepatocellular Carcinoma Treatment and Prognosis, Liver Disease Diagnosis and Treatment, Cholangiocarcinoma and Gallbladder Cancer Studies, Pancreatic and Hepatic Oncology Research, Hepatitis B Virus Studies
Most-Cited Works
- → Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial(2023)431 cited
- → Inactivating mutations of the chromatin remodeling gene ARID2 in hepatocellular carcinoma(2011)421 cited
- → Lenvatinib plus pembrolizumab versus lenvatinib plus placebo for advanced hepatocellular carcinoma (LEAP-002): a randomised, double-blind, phase 3 trial(2023)380 cited
- → Detection of early-stage hepatocellular carcinoma in asymptomatic HBsAg-seropositive individuals by liquid biopsy(2019)175 cited
- → Genetic Features of Aflatoxin-Associated Hepatocellular Carcinoma(2017)172 cited
- → A novel anti-cancer agent Icaritin suppresses hepatocellular carcinoma initiation and malignant growth through the IL-6/Jak2/Stat3 pathway(2015)